气固法合成氯磺化聚乙烯——Ⅱ.氯磺化反应影响因素

以氯化聚乙烯为原料,氯气和二氧化硫为反应气体,紫外光引发,气固法合成了氯磺化聚乙烯。通过元素分析得出,氯磺化反应中不存在氯化和脱氯的副反应。在釜式反应器内研究了氯磺化反应的气固相反应机理,发现气体的内扩散和本征化学反应是氯磺化反应的控制步骤,升高温度（在30－50℃范围内）使氯磺化反应后期的速率显著提高,这是由氯化聚乙烯的共结晶的熔融引起的。还讨论了氯化聚乙烯的链结构和固态结构对氯磺化反应的影响。     

NO在负载型金属氧化物催化剂上的氧化反应机理

研究了γ- Al2 O3负载的金属氧化物催化剂对 NO催化氧化性能。实验发现 ,30 0°C下催化剂活性顺序为 Mn>Cr>Co>Cu>Fe>Ni>Zn,P-型金属氧化物对 NO的氧化活性较强。对 Mn O2这种具有代表性的 P-型金属氧化物催化剂 ,提出了其 NO催化氧化的反应机理和动力学模型。     

气固法合成氯磺化聚乙烯——Ⅰ.气—固相反应机理

以氯化聚乙烯为原料,氯气和二氧化硫为反应气体,紫外光引发,气固法合成了氯磺化聚乙烯。通过元素分析得出,氯磺化反应中不存在氯化和脱氯的副反应。在釜式反应器内研究了氯磺化反应的气固相反应机理,发现气体的内扩散和本征化学反应是氯磺化反应的控制步骤,升高温度（在30－50℃范围内）使氯磺化反应后期的速率显著提高,这是由氯化聚乙烯的共结晶的熔融引起的。还讨论了氯化聚乙烯的链结构和固态结构对氯磺化反应的影响。     

Revision Total Knee Arthroplasty in Young Patients: Higher Early Reoperation and Rerevision

BackgroundRevision total knee arthroplasty (rTKA) rates are increasing in younger patients. Few studies have assessed outcomes of initial aseptic rTKA performed for younger patients compared with traditional-aged patients.MethodsA detailed medical record review was performed to identify patient demographics, medical comorbidities, surgical rTKA indications, timing from index TKA to rTKA, subsequent reoperation rates, component rerevision rates, and salvage procedures for 147 young patients (158 knees) aged 55 years and younger and for a traditional older cohort of 276 patients (300 knees) between 60 and 75 years. Univariate analysis was performed to assess differences in these primary variables, and a log-rank test was used to estimate 5-year implant survival based on either reoperation or component revision and salvage procedures.ResultsYounger TKA patients were more likely to undergo initial aseptic rTKA within 2 years of their primary TKA (52.5% vs 29.0%, P < .001) and were more likely to undergo early reoperation (17.7% vs 9.7%, P = .02) or component rerevision (11.4% vs 6.0%, P < .05) after rTKA. Infection and extensor mechanism complications were more commonly noted in younger patients. Estimated 5-year survival was also lower for both reoperation (59.4% vs 65.7%, P = .02) and component rerevision or salvage (65.8% vs 80.1%, P = .02).ConclusionEarly reoperation and component re-rTKA were performed nearly twice as often in younger rTKA than traditional-aged TKA patients. Care should be given to reduce perioperative infection and extensor mechanism failures after rTKA in younger patients.     

An inverted ankle joint orientation at foot strike could incite ankle inversion sprain: Comparison between injury and non-injured cutting motions of a tennis player

Ankle sprain is very common in sports. Research on its prevention is as important as on its treatment as recommended in the 2016 consensus statement of the International Ankle Consortium. Successful prevention depends on the understanding of its mechanism, which has been presented with quantities in some recent case reports. Inciting event was suggested to be an inverted ankle joint at foot strike, however, is still lacking evidence from comparison with non-injury trials. This study investigated the ankle joint orientation at foot strike in successful non-injury cases and compared them with a previously analysed ankle sprain injury case. Two injury-free cutting motions with similar movement approach to a previously analysed ankle sprain injury performed by the same athlete were collected from an online search and were trimmed from 0.05 s before until 0.30 s after the foot strike. The video sequences were then processed by video editing software and then analysed by a model-based image-matching motion analysis technique. Ankle joint orientation at foot strike and the profiles were presented in inversion, plantarflexion and rotation planes, for both the previously analysed injury case and the two non-injury cases. The ankle joint orientation at foot strike was 0–1 degree inverted and 10–21° dorsiflexed in the two non-injury cases, compared to 14° inverted and 16° plantarflexed in the previously analysed injury case. From the case comparison, it can be observed that an inverted ankle joint orientation at foot strike in an inciting event of ankle inversion sprain.     

Simultaneous bilateral versus unilateral tibial tubercle fractures

PurposeTibial tubercle/tuberosity fractures are rare injuries in young patients accounting for less than one percent of physeal fractures. Bilateral simultaneous fractures are even rarer, with only a few case reports in literature. The purpose of our study was to describe the largest case series of bilateral simultaneous tibial tuberosity avulsion fractures and compare it with unilateral fractures. We also wanted to compare our bilateral fractures case series with all the cases reported in the last 65 years.MethodsIRB approved retrospective study involving patients under age 18 years with tibial tuberosity avulsion fractures. Bilateral simultaneous fractures were compared to a unilateral group including demographic data, mechanism of injury, clinical exam findings, complication rates, and outcomes including return to function. Statistical analysis was performed using Mann-Whitney and Fisher Exact tests to compare the different groups.Results138 patients (131 males, 7 females) from a tertiary children’s hospital between 2012 and 2019 with tibial tuberosity avulsion fractures were included. 11 bilateral simultaneous fractures (BL Group) were identified and compared to age matched cohort from the 127 unilateral fracture patients (UL group). There was no significant difference found in BMI, height, weight, age, sex, mechanism of injury, return to functional range of motion, and return to sports between the groups. 7/11 (63%) of the patients in the BL group who sustained simultaneous fractures had to be home bound and could not attend school for an average of 8.3 weeks. There was a higher rate of complications in the BL group (63.3%) compared to the UL group (21.1%), which was statistically significant. The most common complications in the bilateral group were hardware removal and wound dehiscence.ConclusionThis first case series comparing unilateral versus bilateral simultaneous tibial tuberosity avulsion fractures suggests that the final outcomes of the two groups are similar, however it shows a significantly higher complication rate and hardware removal rate in the BL group. This study is also the first to highlight the significant initial morbidity in the BL fracture group with issues with regards to early mobility and loss of school-days. Keeping in mind the profound initial impact the bilateral injury poses to the patient; surgeons can possibly plan for rigid fixation for early mobilization to better prepare bilateral fracture patients for the early post-operative recovery process.     

3种抗肿瘤有毒蒙药的研究进展

随着社会发展和生活水平的提高,恶性肿瘤已经成为影响人类健康的重大疾病之一。有毒蒙药在治疗疾病及救治疑难杂症中具有重要作用。多种有毒蒙药有一定的抗肿瘤作用,且有着良好的治疗效果,但由于其本身的毒性,使其在临床上的应用受到很大的限制。蒙医在实践中不断摸索出有毒蒙药的多种减毒方法,如采用配伍、炮制等减毒手段进行处理,以达到降低毒性、提高疗效的作用。通过对3种代表性有毒蒙药斑蝥Mylabris、草乌Aconiti Kusnezoffii Radix、瑞香狼毒Stellerae Chamaejasmes Radix的抗肿瘤作用、毒性机制及减毒策略进行综述,为其临床用药及新药开发提供依据。     

基于网络药理学探究防风中生物活性成分及对类风湿关节炎的作用机制

目的 通过以网络药理学为基础的策略研究防风治疗类风湿关节炎（rheumatoid arthritis,RA）的分子生物学机制。方法 采用网络药理学方法收集防风活性成分和治疗RA的潜在靶点,并评估活性成分的药理和毒理学等相关参数;构建蛋白质相互作用网络筛选核心靶点,并通过生物信息学方法进一步验证核心靶点和疾病的关联;对核心成分和相应靶点进行分子对接。体外通过CCK-8实验、细胞迁移和侵袭、细胞凋亡、qRT-PCR和Western blotting分析,阐明别欧前胡素对MH7A细胞磷脂酰肌醇3-激酶（phosphatidylinositol 3-kinase,PI3K）/蛋白激酶B（protein kinase B,Akt）通路的调控作用。结果 从防风中共鉴定出18种活性成分和66个与筛选出的RA疾病靶基因相交的潜在靶基因,最终获得了汉黄芩素、β-谷甾醇、5-O-甲基维斯阿米醇和别欧前胡素等核心成分。防风治疗RA的潜在机制可能是通过调控PI3K/Akt、白细胞介素-17（interleukin-17,IL-17）、凋亡等信号通路和多种生物过程来实现,以发挥抗炎和免疫调节作用。分子对接证实了所有的核心成分和关键靶点均具有很好的对接活性。别欧前胡素抑制MH7A细胞的活力、迁移和侵袭（P＜0.05、0.01）,诱导细胞凋亡（P＜0.01）,并显著下调IL-1β、IL-6、IL-8、基质金属蛋白酶-1（matrix metalloproteinase-1,MMP-1）和MMP-3的基因表达（P＜0.01）。分子分析表明别欧前胡素通过抑制PI3K/Akt通路发挥对MH7A的调控作用。结论 成功预测了防风治疗RA的有效成分和潜在靶点,为进一步探究其分子机制提供了新的理论基础。揭示了别欧前胡素通过PI3K/Akt通路抑制RA成纤维样滑膜细胞的活力、迁移、侵袭及细胞因子和MMPs的表达,并诱导细胞凋亡。     

有机溶液环境下中药成分的纳滤分离机制及适用性研究策略

随着有机溶液在中药制药领域应用的逐渐普遍,涉及到提取、醇沉、树脂洗脱剂成分制备等环节,从而衍生出衔接性的热处理精制引起中药成分转化、溶剂污染等问题。纳滤具有常温化分离优势,但适用于水溶液的分离模型在有机溶液中存在明显的局限性。通过综述纳滤分离机制,结合复杂溶液体系下中药成分的真实状态和传质行为,以期发现适用于有机溶液环境的中药成分纳滤分离研究策略,提升纳滤技术在中药制药领域的适用性,推动中药资源的合理化利用。     

Fifty years of the mitochondrial pyruvate carrier: New insights into its structure,function, and inhibition

The mitochondrial pyruvate carrier (MPC) resides in the mitochondrial inner membrane, where it links cytosolic and mitochondrial metabolism by transporting pyruvate produced in glycolysis into the mitochondrial matrix. Due to its central metabolic role, it has been proposed as a potential drug target for diabetes, non-alcoholic fatty liver disease, neurodegeneration, and cancers relying on mitochondrial metabolism. Little is known about the structure and mechanism of MPC, as the proteins involved were only identified a decade ago and technical difficulties concerning their purification and stability have hindered progress in functional and structural analyses. The functional unit of MPC is a hetero-dimer comprising two small homologous membrane proteins, MPC1/MPC2 in humans, with the alternative complex MPC1L/MPC2 forming in the testis, but MPC proteins are found throughout the tree of life. The predicted topology of each protomer consists of an amphipathic helix followed by three transmembrane helices. An increasing number of inhibitors are being identified, expanding MPC pharmacology and providing insights into the inhibitory mechanism. Here, we provide critical insights on the composition, structure, and function of the complex and we summarize the different classes of small molecule inhibitors and their potential in therapeutics.